News > Pfizer and BioNTech to seek emergency Covid-19 vaccine approval in US Friday

Pfizer and BioNTech to seek emergency Covid-19 vaccine approval in US Friday

An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday. This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic.

“Pfizer’s partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA,” health secretary Alex Azar said.